Blog Category:

Impact of Psoriasis and Psoriatic Arthritis: What Matters When Engaging with Patients

Psoriasis (PsO) is a disease in which rough, scaly patches of skin develop on a significant portion of the body, most commonly the knees, elbows, trunk, and scalp. This condition has daily negative implications for quality of life that include …

Clinical Pathways in T2D Care: Overcoming Inertia, Implementing Innovation

Clinicians treating patients with T2D need to know how to choose and optimally use incretin therapies that have activity against common comorbidities in T2D, including obesity and CVD. Over the past decade there have been several new classes of drugs …

Up for Debate: Effective First-line Maintenance Strategies for Advanced Ovarian Cancer

Recent data has led to a debate of the most effective maintenance strategy for advanced OC. Emerging data utilizing novel approaches to maintenance both further complicates the debate and sheds new light on novel effective strategies for maintenance therapy for …

Tailoring Care: Crafting Individualized and Patient-Centered Narcolepsy Treatment Plans

Patients with narcolepsy experience excessive daytime sleepiness, cataplexy, disrupted night-time sleep, hypnagogic hallucinations, and sleep paralysis. Patients frequently cope with these symptoms for years, at great expense to their quality of life, and often have to see multiple specialists before …

Now More Than Ever: A Mycophenolate REMS Escape Room Challenge

Mycophenolate is the most common immunosuppressant used for preventing organ rejection in transplant recipients and is frequently employed in other disciplines, such as rheumatology. In response to the discovery of fetal teratogenicity associated with mycophenolate use during pregnancy, the FDA …

Deciphering Narcolepsy: Analyzing Signs and Symptoms for Early Diagnosis

Narcolepsy is a chronic sleep disorder that affects approximately one in 2,000 individuals. The patient’s diagnostic journey is often long and complex, and narcolepsy frequently remains undiagnosed or is misdiagnosed as other conditions, including depression, schizophrenia, insomnia, or obstructive sleep …

Exploring Innovative Treatments: Appraising Novel Pharmacotherapies for Narcolepsy

Narcolepsy is a chronic sleep disorder that carries a high degree of disability and comorbidity. Patients often wait years for a proper diagnosis and treatment initiation, resulting in a tremendous negative impact to their quality of life. Pharmacotherapy for narcolepsy…

Deciphering Patient Selection Related to Current and Emerging Amyloid-Targeting Therapies (ATTs)

The emerging class of amyloid-targeting therapies (ATTs) are at the forefront of innovative approaches that promise to alter the course of Alzheimer’s disease (AD). However, the translation of these scientific advancements into clinical practice necessitates a well-informed clinical workforce adept …

Untangling the Data: pTau and Neurofibrillary Tangles as Part of Early Alzheimer’s Detection

Alzheimer’s disease (AD) presents a growing challenge in contemporary health care, with escalating prevalence and a significant burden imposed on patients, families, and health care systems globally. Early and accurate diagnosis of AD is essential for effective support and treatment. …